Comparison of laparoscopy versus mini-laparotomy for jejunostomy placement in patients with gastric adenocarcinoma.

Alimentation Feeding access Gastroesophageal adenocarcinoma Jejunostomy Laparoscopy Minimally invasive surgery Nutrition

Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
12 2021
Historique:
received: 30 05 2020
accepted: 04 11 2020
pubmed: 11 11 2020
medline: 5 1 2022
entrez: 10 11 2020
Statut: ppublish

Résumé

Optimal nutrition is challenging for patients with gastric and gastroesophageal adenocarcinoma and often requires feeding tube placement prior to preoperative therapy. Feeding jejunostomy (FJ) placement via mini-laparotomy is technically easier to perform than laparoscopic FJ. The purpose of this study was to compare outcomes in patients with gastric adenocarcinoma undergoing laparoscopic versus mini-laparotomy FJ placement. A retrospective cohort study was performed of patients with gastric adenocarcinoma receiving laparoscopic versus mini-laparotomy FJ at a single tertiary referral center from 2000 to 2018. 30-day outcomes included complications, conversion to laparotomy, reoperation, length of stay, and readmission. A total of 656 patients met the inclusion criteria and were studied. The majority of patients were male (68.1%) with a mean age of 60.6 years. The difference in surgical approach remained relatively stable over time. Overall, 82 (12.5%) patients experienced complications, and three (0.5%) patients died postoperatively. While readmission and conversion to open laparotomy did not differ between groups, overall complications (10.5% vs. 20.8%, p = 0.002), Clavien-Dindo ≥ 3 complications (4.0% vs. 8.9%, p = 0.021), length of stay (4.1 vs. 5.6 days, p < 0.001), and reoperation (0.9% vs. 4.0%, p = 0.002) favored the laparoscopic over mini-laparotomy group. The current study helps clarify the risk of FJ placement in patients with gastric adenocarcinoma requiring nutritional support. Laparoscopic FJ placement has lower overall morbidity and length of stay compared to mini-laparotomy. However, caution is needed in preventing and identifying the rare causes of postoperative mortality that may be associated with laparoscopic FJ placement.

Sections du résumé

BACKGROUND
Optimal nutrition is challenging for patients with gastric and gastroesophageal adenocarcinoma and often requires feeding tube placement prior to preoperative therapy. Feeding jejunostomy (FJ) placement via mini-laparotomy is technically easier to perform than laparoscopic FJ. The purpose of this study was to compare outcomes in patients with gastric adenocarcinoma undergoing laparoscopic versus mini-laparotomy FJ placement.
METHODS
A retrospective cohort study was performed of patients with gastric adenocarcinoma receiving laparoscopic versus mini-laparotomy FJ at a single tertiary referral center from 2000 to 2018. 30-day outcomes included complications, conversion to laparotomy, reoperation, length of stay, and readmission.
RESULTS
A total of 656 patients met the inclusion criteria and were studied. The majority of patients were male (68.1%) with a mean age of 60.6 years. The difference in surgical approach remained relatively stable over time. Overall, 82 (12.5%) patients experienced complications, and three (0.5%) patients died postoperatively. While readmission and conversion to open laparotomy did not differ between groups, overall complications (10.5% vs. 20.8%, p = 0.002), Clavien-Dindo ≥ 3 complications (4.0% vs. 8.9%, p = 0.021), length of stay (4.1 vs. 5.6 days, p < 0.001), and reoperation (0.9% vs. 4.0%, p = 0.002) favored the laparoscopic over mini-laparotomy group.
CONCLUSION
The current study helps clarify the risk of FJ placement in patients with gastric adenocarcinoma requiring nutritional support. Laparoscopic FJ placement has lower overall morbidity and length of stay compared to mini-laparotomy. However, caution is needed in preventing and identifying the rare causes of postoperative mortality that may be associated with laparoscopic FJ placement.

Identifiants

pubmed: 33170336
doi: 10.1007/s00464-020-08155-6
pii: 10.1007/s00464-020-08155-6
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6577-6582

Informations de copyright

© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Badgwell B, Das P, Ajani J (2017) Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy. J Hematol Oncol 10(1):149. https://doi.org/10.1186/s13045-017-0517-9
doi: 10.1186/s13045-017-0517-9 pubmed: 28810883 pmcid: 5558742
National Comprehensive Cancer Network Guidelines Version 4.2019, Gastric Cancer. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf . Accessed 10 Jan 2020
Jenkinson AD, Lim J, Agrawal N, Menzies D (2007) Laparoscopic feeding jejunostomy in esophagogastric cancer. Surg Endosc 21(2):299–302. https://doi.org/10.1007/s00464-005-0727-z
doi: 10.1007/s00464-005-0727-z pubmed: 17122985
Sun Z, Shenoi MM, Nussbaum DP et al (2016) Feeding jejunostomy tube placement during resection of gastric cancers. J Surg Res 200(1):189–194. https://doi.org/10.1016/j.jss.2015.07.014
doi: 10.1016/j.jss.2015.07.014 pubmed: 26248478
Dann GC, Squires MH, Postlewait LM et al (2015) An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: a seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative. J Surg Oncol 112(2):195–202. https://doi.org/10.1002/jso.23983
doi: 10.1002/jso.23983 pubmed: 26240027
Weijs TJ, Berkelmans GH, Nieuwenhuijzen GA et al (2015) Routes for early enteral nutrition after esophagectomy. A systematic review. Clin Nutr 34(1):1–6. https://doi.org/10.1016/j.clnu.2014.07.011
doi: 10.1016/j.clnu.2014.07.011 pubmed: 25131601
Elshaer M, Gravante G, White J, Livingstone J, Riaz A, Al-Bahrani A (2016) Routes of early enteral nutrition following oesophagectomy. Ann R Coll Surg Engl 98(7):461–467. https://doi.org/10.1308/rcsann.2016.0198
doi: 10.1308/rcsann.2016.0198 pubmed: 27388543 pmcid: 5210017
Gerritsen A, Besselink MG, Cieslak KP et al (2012) Efficacy and complications of nasojejunal, jejunostomy and parenteral feeding after pancreaticoduodenectomy. J Gastrointest Surg 16(6):1144–1151. https://doi.org/10.1007/s11605-012-1887-5
doi: 10.1007/s11605-012-1887-5 pubmed: 22528573 pmcid: 3354327
Siow SL, Mahendran HA, Wong CM, Milaksh NK, Nyunt M (2017) Laparoscopic T-tube feeding jejunostomy as an adjunct to staging laparoscopy for upper gastrointestinal malignancies: the technique and review of outcomes. BMC Surg 17(1):25. https://doi.org/10.1186/s12893-017-0221-2
doi: 10.1186/s12893-017-0221-2 pubmed: 28320382 pmcid: 5359869
Ikoma N, Blum M, Chiang YJ et al (2016) Yield of staging laparoscopy and lavage cytology for radiologically occult peritoneal carcinomatosis of gastric cancer. Ann Surg Oncol 23(13):4332–4337. https://doi.org/10.1245/s10434-016-5409-7
doi: 10.1245/s10434-016-5409-7 pubmed: 27384751
Gerndt SJ, Orringer MB (1994) Tube jejunostomy as an adjunct to esophagectomy. Surgery 115(2):164–169
pubmed: 8310404
Gupta V (2009) Benefits versus risks: a prospective audit. Feeding jejunostomy during esophagectomy. World J Surg 33(7):1432–1438. https://doi.org/10.1007/s00268-009-0019-1
doi: 10.1007/s00268-009-0019-1 pubmed: 19387726
Llaguna OH, Kim HJ, Deal AM, Calvo BF, Stitzenberg KB, Meyers MO (2011) Utilization and morbidity associated with placement of a feeding jejunostomy at the time of gastroesophageal resection. J Gastrointest Surg 15(10):1663–1669. https://doi.org/10.1007/s11605-011-1629-0
doi: 10.1007/s11605-011-1629-0 pubmed: 21796458
Kroese TE, Tapias L, Olive JK, Trager LE, Morse CR (2019) Routine intraoperative jejunostomy placement and minimally invasive oesophagectomy: an unnecessary step? Eur J Cardiothorac Surg 56(4):746–753. https://doi.org/10.1093/ejcts/ezz063
doi: 10.1093/ejcts/ezz063 pubmed: 30907417
Patel SH, Kooby DA, Staley CA, Maithel SK (2013) An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma. J Surg Oncol 107(7):728–734. https://doi.org/10.1002/jso.23324
doi: 10.1002/jso.23324 pubmed: 23450704
Wheble GA, Benson RA, Khan OA (2012) Is routine postoperative enteral feeding after oesophagectomy worthwhile? Interact Cardiovasc Thorac Surg 15(4):709–712. https://doi.org/10.1093/icvts/ivs221
doi: 10.1093/icvts/ivs221 pubmed: 22753430 pmcid: 3445352
Choi AH, O’Leary MP, Merchant SJ et al (2017) Complications of feeding jejunostomy tubes in patients with gastroesophageal cancer. J Gastrointest Surg 21(2):259–265. https://doi.org/10.1007/s11605-016-3297-6
doi: 10.1007/s11605-016-3297-6 pubmed: 27785689

Auteurs

Catherine H Davis (CH)

Department of Surgery, Houston Methodist Hospital, Houston, TX, USA.

Naruhiko Ikoma (N)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Herman Pressler, Unit 1484, Houston, TX, 77030, USA.

Paul F Mansfield (PF)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Herman Pressler, Unit 1484, Houston, TX, 77030, USA.

Prajnan Das (P)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Bruce D Minsky (BD)

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mariela A Blum (MA)

Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jaffer A Ajani (JA)

Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Barbara L Bass (BL)

Department of Surgery, Houston Methodist Hospital, Houston, TX, USA.

Brian D Badgwell (BD)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Herman Pressler, Unit 1484, Houston, TX, 77030, USA. bbadgwell@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH